BrainStorm Cell Therapeutics
BCLI
#10103
Rank
NZ$12.21 M
Marketcap
$1.87
Share price
14.87%
Change (1 day)
-86.25%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2024 (TTM): -NZ$19.41 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. . The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$19.44 Million
2022 -NZ$40.59 Million-0.74%
2021 -NZ$40.89 Million-23.12%
2020 -NZ$53.19 Million36.8%
2019 -NZ$38.88 Million66.71%
2018 -NZ$23.32 Million181.66%
2017 -NZ$8.28 Million-0.6%
2016 -NZ$8.33 Million-41.31%
2015 -NZ$14.2 Million-8.22%
2014 -NZ$15.47 Million89.74%
2013 -NZ$8.15 Million42.27%
2012 -NZ$5.73 Million-12.45%
2011 -NZ$6.55 Million63.04%
2010 -NZ$4.02 Million35.52%
2009 -NZ$2.97 Million-48.99%
2008 -NZ$5.81 Million-44.39%
2007 -NZ$10.44 Million
2005 -NZ$5.41 Million-91.44%
2004 -NZ$63.17 Million94007.62%
2003 -NZ$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$1.15 B-6,036.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.99 Billion 4,972.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.33 Billion 6,701.82%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.18 B-16,498.52%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.2 Billion 886.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.43 Billion 2,098.13%๐Ÿ‡บ๐Ÿ‡ธ USA